Chao Cao

Dr. Cao is an instructor at Dana-Farber Cancer Institute/Harvard Medical School. His current research interests include 1) evaluating the prevalence of risk factors and the disease burden of cancer-related comorbidities and complications among cancer survivors at the population level; 2) examining the impact of energy-balance behaviors (physical activity, sedentary behavior, sleep, and diet), mental health issues (depression and suicidal ideation), metabolic risks (obesity and insulin resistance), and cardiotoxicity (NT-proBNP and troponin) on health and survival outcomes among cancer survivors; and 3) developing equitable strategies to implement evidence-based interventions that reduce death rates, the comorbidity burden, and improve the quality of life for cancer survivors.
 

Dr. Cao has published 70 peer-reviewed manuscripts in leading medical journals including JAMA, JAMA Oncology, JAMA Otolaryngology, Metabolism, Diabetes, JCO, JNCI, etc., with extensive media coverage (Associated Press, CNN, Time, The Wall Street Journal, The Guardian, Reuters, New York Times etc.).